Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Restructuring Costs: 2021-2024

Historic Restructuring Costs for Collegium Pharmaceutical (COLL) over the last 4 years, with Dec 2024 value amounting to $33.7 million.

  • Collegium Pharmaceutical's Restructuring Costs rose 39.88% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.5 million, marking a year-over-year increase of 50.89%. This contributed to the annual value of $33.7 million for FY2024, which is 4.27% up from last year.
  • As of FY2024, Collegium Pharmaceutical's Restructuring Costs stood at $33.7 million, which was up 4.27% from $32.3 million recorded in FY2023.
  • Collegium Pharmaceutical's Restructuring Costs' 5-year high stood at $33.9 million during FY2022, with a 5-year trough of $4.6 million in FY2021.
  • Moreover, its 3-year median value for Restructuring Costs was $33.7 million (2024), whereas its average is $33.3 million.
  • Its Restructuring Costs has fluctuated over the past 5 years, first soared by 640.83% in 2022, then dropped by 4.70% in 2023.
  • Collegium Pharmaceutical's Restructuring Costs (Yearly) stood at $4.6 million in 2021, then soared by 640.83% to $33.9 million in 2022, then dropped by 4.70% to $32.3 million in 2023, then increased by 4.27% to $33.7 million in 2024.